CETUFTIRI, a new combination of UFT with leucovorin (LV), irinotecan, and cetuximab as first-line treatment for patients (pts) with unresectable metastatic colorectal cancer (mCRC): Preliminary results from a multicenter phase II trial

被引：0
|
作者：
Bennouna, J.
Faroux, R.
Francois, E.
Ligeza, C.
El Hannani, C.
Perrier, H.
Jacob, J.
Desseigne, F.
Perrocheau, G.
Douillard, J. Y.
机构：
[1] Ctr Rene Gauducheau, St Herblain, France
[2] Ctr Hosp La Roche Sur Yon, La Roche Sur Yon, France
[3] Ctr Antoine Lacassagne, Nice, France
[4] Ctr Etienne Dolet, St Nazaire, France
[5] Ctr Hosp Chateaubriand, Chateaubriand, France
[6] Hop St Joseph, Marseille, France
[7] Ctr Francois Baclesse, Caen, France
[8] Ctr Leon Berard, Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4087
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)
    Klaassen, U
    Lang, S
    Borquez, D
    Oberhoff, C
    Benner, S
    Harstrick, A
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S322 - S323
  • [32] Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (541.1) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase
    Souglakos, J
    Ziras, N
    Polyzos, A
    Athanasiadis, A
    Kakolyris, S
    Giannakakis, T
    Tselepatiotis, E
    Kalbakis, K
    Vardakis, N
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 253S - 253S
  • [33] Cetuximab with irinotecan in first-line treatment of epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC): Preliminary safety results (CRYSTAL).
    Lang, I.
    Zaluski, J.
    Changchien, C. R.
    Makhson, A.
    Pinter, T.
    D'Haens, G.
    Lim, R.
    Nippgen, J.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 159S - 159S
  • [34] A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer
    Boccia, Ralph V.
    Cosgriff, Thomas M.
    Headley, David L.
    Badarinath, Suprith
    Dakhil, Shaker R.
    CLINICAL COLORECTAL CANCER, 2010, 9 (02) : 102 - 107
  • [35] Multicenter phase II trial of S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable colorectal cancer
    Shin, S.
    Park, Y.
    Kim, T.
    Oh, D.
    Shim, B.
    Lee, K.
    Lee, M.
    Kim, Y.
    Kim, Y.
    Ahn, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Phase I/II study of irinotecan, UFT, and leucovorin with hepatic arterial infusion in colorectal cancer patients with unresectable liver metastases: Preliminary results
    Yamaguchi, T.
    Matsumoto, H.
    Takahashi, K.
    Yasutome, M.
    Mori, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Modified FOLFOXIRI plus cetuximab (cet) as induction treatment in unresectable metastatic colorectal cancer (mCRC) patients (pts): Preliminary results of the phase II randomized Macbeth trial by GONO group.
    Cremolini, Chiara
    Loupakis, Fotios
    Salvatore, Lisa
    Lonardi, Sara
    Battaglin, Francesca
    Gamucci, Teresa
    Grande, Roberta
    Di Fabio, Francesca
    Liimpe, Fabiola Lorena Rojas
    Ferrari, Laura
    Casagrande, Mariaelena
    Lucchesi, Sara
    Tonini, Giuseppe
    Banzi, Maria
    Valsuani, Chiara
    Corsi, Domenico C.
    Fontanini, Gabriella
    Tomcikova, Daniela
    Boni, Luca
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] IMPACT ON QUALITY OF LIFE OF CETUXIMAB PLUS FOLFIRI IN THE FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM THE CRYSTAL TRIAL
    Lang, I
    Aleknaviciene, B.
    Zolotukhin, S.
    Komissarenko, V
    Garcia-Alfonso, P.
    Jurga, L.
    Moiseyenko, V
    Filipczyk-Cisarz, E.
    Zubel, A.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2009, 20 : 23 - 24
  • [39] Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
    Sheikh, H. Y.
    Valle, J. W.
    Palmer, K.
    Sjursen, A.
    Craven, O.
    Wilson, G.
    Swindell, R.
    Saunders, M. P.
    BRITISH JOURNAL OF CANCER, 2007, 96 (01) : 38 - 43
  • [40] Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
    H Y Sheikh
    J W Valle
    K Palmer
    A Sjursen
    O Craven
    G Wilson
    R Swindell
    M P Saunders
    British Journal of Cancer, 2007, 96 : 38 - 43
12345